Full Coverage

ZIOPHARM Oncology Reports First Quarter Results

                   
genengnews.com: Genetic Engineering genengnews.com
genengnews.com
May 12, 2008
        
Story Timeline:  193 days

News source: Business Wire ZIOPHARM Oncology, Inc. today reported financial results for the three months ended March 31, 2008. Presentation of promising early data from phase Ib study of indibulin at 6th International Symposium on Targeted Anticancer Therapies; results... [read full story]                    

Add Comment
Latest article on this story:

ZIOPHARM Oncology Inc receives Notices of Allowance in US

 m2.com May 14, 2008
First article on this story:

ZIOPHARM Oncology to Present at Rodman and Renshaw 5th Annual Global Healthcare Conference

 euroinvestor.co.uk May 12, 2008
Selected publications with coverage of this story:
genengnews.com euroinvestor.co.uk m2.com finanznachrichten.de
RELATED
Found 3 documents:

ZIOPHARM Oncology Inc receives Notices of Allowance in US

m2.com
May 14, 2008
        

ZIOPHARM Oncology Inc (NASDAQ:ZIOP), a biopharmaceutical company, reported on 13 May the receipt of Notices of Allowance from the US Patent and Trademark Office for patent applications numbered 11/252,966 and 11/349,043 covering darinaparsin. The company

                   
genengnews.com: Genetic Engineering genengnews.com

ZIOPHARM Receives Notices of Allowance for Two U.S. Patent Applications Covering Darinaparsin

genengnews.com
May 13, 2008
        

News source: Business Wire ZIOPHARM Oncology, Inc. announced today that it has received Notices of Allowance from the U.S. Patent and Trademark Office for patent applications numbered 11/252,966 and 11/349,043, covering claims for various organic arsenic compounds, including purified crystalline...

                   

ZIOPHARM Receives Notices of Allowance for Two U.S. Patent Applications Covering Darinaparsin

finanznachrichten.de
May 13, 2008
        

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced today that it has received Notices of Allowance from the U.S. Patent and Trademark Office for patent applications numbered 11/252,966 and 11/349,043, covering claims for various organic arsenic compounds, including purified crystalline...